Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,395.00p
   
  • Change Today:
    -75.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 135,960
  • Market Cap: £1,593.58m
  • RiskGrade: 128
  • Beta: 1.30

Deal with Barclays    Trade now with Barclays Stockbrokers

Genus taps Andy Russell for CFO

By Iain Gilbert

Date: Thursday 13 Mar 2025

LONDON (ShareCast) - (Sharecast News) - Animal genetics business Genus revealed on Thursday that it had appointed Andy Russell to the role of chief financial officer.
Russell will join Genus on 1 August, taking over from Alison Henriksen, who will retire from Genus on 31 July after more than five years in the job.

Russell joins Genus from global medical device manufacturer Smith & Nephew, where he spent nearly 12 years as CFO.

Chief executive Jorgen Kokke said: "I am delighted that we have been able to secure an executive of Andy's caliber. His blend of deep finance expertise and strong commercial acumen will help us take Genus through the next stage of its development as we continue to pursue our strategic priorities".

As of 0930 GMT, Genus shares were up 0.63% at 1,926.0p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,395.00p
Change Today -75.00p
% Change -3.04 %
52 Week High 2,715.00
52 Week Low 1,424.00
Volume 135,960
Shares Issued 66.54m
Market Cap £1,593.58m
Beta 1.30
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 06-Nov-2025

Time Volume / Share Price
15:50 20,296 @ 2,371.16p
16:37 13,818 @ 2,395.00p
16:35 784 @ 2,395.00p
16:35 8 @ 2,395.00p
16:35 32,149 @ 2,395.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page